Halothane and isoflurane dose-dependently inhibit the cyclic GMP increase caused by N-methyl-D-aspartate in rat cerebellum: Novel localization and quantitation by in vitro autoradiography

Neuroscience

Volumn 74, Issue 4, 1996, Pages 1069-1075

  Zuo, Z ^a   De Vente, J ^b   Johns, R A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Brain; Guanylyl cyclase; Inhalational anesthetics; Nitric oxide; Nitric oxide synthase

Indexed keywords

ANESTHETIC AGENT; CYCLIC GMP; HALOTHANE; ISOFLURANE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CEREBELLUM; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030271251     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(96)00182-0     Document Type: Article

References (24)

1. 1. Bradford M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt. Biochem 72, 248-254.
2. 2. Bredt D. S., Hwang P. M. and Snyder S. H. (1990) Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347, 768-770.
3. 3. Bredt D. S. and Snyder S. H. (1989) Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. natn. Acad. Sci. U.S.A. 86, 9030-9033.
4. 4. Brown J. and Zuo Z. (1992) Renal receptors for atrial and C-type natriuretic peptides in the rat. Am. J. Physiol. 263, F89-F96.
5. 5. Brown J. and Zuo Z. (1993) C-type natriuretic peptide and atrial natriuretic peptide receptors of rat brain. Am. J. Physiol. 264, R513-R523.
6. 6. Chevalier R. L., Fern R. J., Garmey M., El-Dahr S. S., Gomez R. A. and De Vente J. (1992) Localization of cGMP after infusion of ANP or nitroprusside in the maturing rat. Am. J. Physiol. 262, F417-F424.
7. 7. De Vente J. and Steinbusch H. W. M. (1992) On the stimulation of soluble and particulate guanylate cyclase in the rat brain and the involvement of nitric oxide as studied by cGMP immunocytochemistry. Acta histochem. 92, 13-28.
8. 8. Garthwaite J. and Garthwaite G. (1987) Cellular origins of cyclic GMP responses to excitatory amino acid receptor agonists in rat cerebellum in vitro. J. Neurochem. 48, 29-39.
9. 9. Garthwaite J., Charles S. L. and Chess-Williams R. (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336, 385-388.
10. 10. Johns R. A., Moscicki J. C. and DiFazio C. A. (1992) Nitric oxide synthase inhibitor dose-dependently and reversibly reduces the threshold for halothane anesthesia. Anesthesiology 77, 779-784.
11. 11. Kant G. J., Muller T. W., Lenox R. H. and Meyerhoff J. L. (1980) In vivo effects of pentobarbital and halothane anesthesia on levels of adenosine 3′,5′-monophosphate and guanosine 3′, 5′-monophosphate in rat brain regions and pituitary. Biochem. Pharmac. 29, 1891-1896.
12. G-nitro-arginine binding in the rat brain. Neuropharmacology 34, 63-73.
13. 13. Knowles R. G. and Moncada S. (1994) Nitric oxide synthases in mammals. Biochem. J. 298, 249-258.
14. 14. Knowles R. G., Palacios M., Palmer R. M. J. and Moncada S. (1989) Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylyl cyclase. Proc. natn. Acad. Sci. U.S.A. 86, 5159-5162.
15. 15. Nakamura K. and Mori K. (1993) Nitric oxide and anesthesia. Anesth. Analg. 77, 877-879.
16. 16. Pajewski T., DiFazio C., Moscicki J. and Johns R. A. (1995) The neuronally-selective nitric oxide synthase inhibitor 7-nitro indazole dose-dependently reduces the threshold for halothane and isoflurane anesthesia in rats (Abstract). Anesthesiology 83, A694.
17. 17. Pearce R. A., Stringer J. L. and Lothman E. W. (1989) Effect of volatile anesthetics on synaptic transmission in the rat hippocampus. Anesthesiology 71, 591-598.
18. 18. Richards C. D. and Smaje J. C. (1976) Anesthetics depress the sensitivity of cortical neurones to L-glutamate. Br. J. Pharmac. 58, 347-357.
19. 19. Shuttleworth C. W., Xue C., Ward S. M., De Vente J. and Sanders K. M. (1993) Immunohistochemical localization of 3′,5′-cyclic guanosine monophosphate in the canine proximal colon: responses to nitric oxide and electrical stimulation of enteric inhibitory neurons. Neuroscience 56, 513-522.
20. 20. Southam E. and Garthwaite J. (1993) The nitric oxide-cyclic GMP signaling pathway in rat brain. Neuropharmacology 32, 1267-1277.
21. 21. Terasako K., Nakamura K., Miyawaki I., Toda H., Kakuyama M. and Mori K. (1994) Inhibitory effects of anesthetics on cyclic guanosine monophosphate (cGMP) accumulation in rat cerebellar slices. Anesth. Analg. 79, 921-926.
22. 22. Uggeri M. J., Proctor G. J. and Johns R. A. (1992) Halothane, enflurane, and isoflurane attenuate both receptor-and non-receptor-mediated EDRF production in the rat thoracic aorta. Anesthesiology 76, 1012-1017.
23. 23. Wood P. L. (1991) Pharmacology of the second messenger, cyclic guanosine 3′,5′-monophosphate, in the cerebellum. Pharmac. Rev. 43, 1-25.
24. 24. Wood P. L., Ryan R. and Li M. (1992) Excitatory amino acid signal transduction in the hippocampus: role of noradrenegic afferents and nitric oxide in the cGMP increases in vivo. Life Sci. 51, 601-606.